The Proteomics Centers Program was
established in 2010 with the goal of applying proteomic approaches
to gain a better mechanistic understanding of the physiologic
pathways underlying defined clinical conditions related to heart,
lung, and blood diseases. Given the rapid developments in proteomic
technologies and approaches in the last five years, it is important
to determine the extent to which the efforts of the centers have
matured, leading to discovery of new targets for intervention and
clinically actionable tool sets. An eighteen-month outcome
evaluation will coincide with the completion of funding for the
program. This information collection request is being made for one
component of this evaluation: semi-structured interviews with key
informants across four targeted groups, internal and external to
the program.
US Code:
42 USC 285b–3 Name of Law: National Heart, Blood Vessel, Lung
and Blood Diseases and Blood Resources Program
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.